Wide reagent range for COVID-19 assay development

Together EastCoast Bio, Lee Biosolutions and Medix Biochemica offer a wide range of critical reagents for COVID-19 assay development. Products from each portfolio include:
- Anti-SARS-CoV-2 Nucleocapsid monoclonal antibodies – NEW
- Anti-SARS-CoV-2 Spike 1 protein monoclonal antibodies – NEW
- Recombinant SARS-CoV-2 Spike 1 and Nucleocapsid antigens
- COVID-19 cross-reactivity serum/plasma panel – NEW
- COVID-19 confirmed positive & negative serum/plasma samples
– NEW SAMPLES - COVID-19 confirmed positive & negative nasopharyngeal swabs
- Nasal fluid and sputum samples collected prior to November 2019
- Recombinant SARS-CoV-2 Nucleocapsid, Spike 1, Spike RBD antigens
- Anti-IgG, IgM, and IgA monoclonal antibodies for your serological assays
Please do not hesitate to contact us for more information.